|Bid||119.71 x 1200|
|Ask||119.87 x 900|
|Day's Range||116.43 - 123.58|
|52 Week Range||21.05 - 128.13|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The U.S. preparing for vaccine distribution as early as next week.
The UK government has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, becoming the first country to do so for widespread use. Yahoo Finance’s Anjalee Khemlani breaks down the details.
Wall Street stocks were mixed on Wednesday, with the Nasdaq dipping and S&P 500 index climbing as investors weighed upbeat vaccine developments and a potential coronavirus fiscal package with a bleak private jobs report. In the latest upbeat development, Pfizer Inc and BioNTech's COVID-19 vaccine got the green light for use in Britain, the first Western country to approve a shot for COVID-19. Pfizer rose 3% and BioNTech jumped 5%.